Showing results (401-410 of 597) with videos related to
Sort By:
Pageof 60
Journal of the American College of Cardiology|July 5, 2005
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingRoberto Corti, Valentin Fuster, Zahi A Fayad, et al.Journal of the American College of Cardiology|April 20, 2019
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial EnergeticsCarlos G Santos-Gallego, Juan Antonio Requena-Ibanez, Rodolfo San Antonio, et al.Circulation. Cardiovascular Interventions|August 4, 2017
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorM Urooj Zafar, Donald A Smith, Usman Baber, et al.Nature Cardiovascular Research|August 28, 2024
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failureChristiane E Angermann, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, et al.Journal of the American College of Cardiology|March 5, 2025
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ReviewFrans J Beerkens, Gilbert H L Tang, Annapoorna S Kini, et al.American Heart Journal|September 25, 2024
Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain studyCatarina Tristão-Pereira, Valentin Fuster, Alejandro Lopez-Jimenez, et al.JACC. Cardiovascular Imaging|May 16, 2009
Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosisMichael J Lipinski, Juan C Frias, Vardan Amirbekian, et al.Nature Clinical Practice. Cardiovascular Medicine|August 20, 2008
The use of high-sensitivity assays for C-reactive protein in clinical practiceKiran Musunuru, Brian G Kral, Roger S Blumenthal, et al.Journal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.Cardiovascular Diabetology|December 20, 2023
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosisJosep Iglesies-Grau, Ana Garcia-Alvarez, Belén Oliva, et al.Pageof 60